Rigel Pharmaceuticals
RIGL
RIGL
92 hedge funds and large institutions have $193M invested in Rigel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
8.47% more ownership
Funds ownership: 59.18% → 67.65% (+8.5%)
2% more funds holding
Funds holding: 90 → 92 (+2)
61% less call options, than puts
Call options by funds: $2.83M | Put options by funds: $7.22M
Holders
92
Holding in Top 10
2
Calls
$2.83M
Puts
$7.22M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$7.15M | |
| 3 | +$4.69M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$1.98M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.86M |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$1.76M | |
| 3 | -$1.42M | |
| 4 |
Jane Street
New York
|
-$1.3M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.12M |